收藏切换
Research progress of plasminogen in the treatment of congenital plasminogen deficiency
收藏切换
Lijie YU1, Lei WANG1, Ting WANG1, Hui ZHANG1, Junlong WANG1, *, Wei WANG2, *
World Clinical Drug | 2024, 45(4) : 364 - 367
Less
收藏切换
World Clinical Drug | 2024, 45(4): 364-367
• Topic •
Research progress of plasminogen in the treatment of congenital plasminogen deficiency
Full
Lijie YU1, Lei WANG1, Ting WANG1, Hui ZHANG1, Junlong WANG1, *, Wei WANG2, *
Affiliations
  • 1.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China
  • 2.Outpatient Department of Pediatrics, the First Hospital of Jilin University, Changchun 130000, Jilin Province, China
Published: 2024-04-10 doi: 10.13683/j.wph.2024.04.003
Outline
收藏切换

Congenital plasminogen deficiency (C-PLGD), also referred to as type Ⅰ plasminogen deficiency, plasminogen deficiency or hypoplasminogenemia, is an ultra-rare autosomal recessive disorder of the fibrinolytic system, which is mainly manifested by the abnormal extravascular accumulation and growth of fibrin-rich, ligneous pseudomembranous lesions on mucous membranes throughout the body. Left untreated, these lesions may impair normal tissue and organ function, and impact patients' quality of life. Currently, there is no specific replacement therapy approved for the treatment of C-PLGD in China. As such, treatment options have been limited to non-specific therapies and interventions, including surgery, all of which have been proved to be less effective. Foreign clinical trials have shown that replacement therapy with human glutamate-plasminogen can consistently increase plasminogen activity and improve the clinical symptoms of C-PLGD patients, and it is well tolerated. This article provided an overview of the research progress on the treatment of C-PLGD with human plasminogen, in order to provide some ideas and basis for its clinical application and research in the treatment of plasminogen deficiency.

congenital plasminogen deficiency  /  igneous pseudomembranous lesions  /  glutamate-plasminogen
于丽杰, 王磊, 王婷, 张慧, 王俊龙, 王伟. 人纤溶酶原治疗先天性纤溶酶原缺乏症的研究进展. 世界临床药物, 2024 , 45 (4) : 364 -367 . DOI: 10.13683/j.wph.2024.04.003
Lijie YU, Lei WANG, Ting WANG, Hui ZHANG, Junlong WANG, Wei WANG. Research progress of plasminogen in the treatment of congenital plasminogen deficiency[J]. World Clinical Drug, 2024 , 45 (4) : 364 -367 . DOI: 10.13683/j.wph.2024.04.003
Year 2024 volume 45 Issue 4
20
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.04.003
  • Receive Date:2024-01-09
  • Online Date:2026-11-17
  • Published:2024-04-10
Article Data
Affiliations
History
  • Received:2024-01-09
Affiliations
    1.Shanghai InnoClinic Pharmaceutical Developmeng Co., Ltd., Shanghai 200437, China
    2.Outpatient Department of Pediatrics, the First Hospital of Jilin University, Changchun 130000, Jilin Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.04.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT